One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1182/blood-2020-141917
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2020 |
 Citations: 6 |
Affiliation: Columbia University Irving Medical Center, Therapeutics Clinical Research, Emory University, The University of Texas MD Anderson Cancer Center, University of California, San Diego, University of California, Davis, Christ Hospital, Feinstein Institute for Medical Research, Yale University, Louisiana State University Health Sciences Center New Orleans, City Of Hope National Medical CenterCirmtuzumab, an Anti-ROR1 Antibody, in Combination with Ibrutinib: Clinical Activity in Mantle Cell Lymphoma (MCL) or Chronic Lymphocytic Leukemia (CLL) from a Phase 1/2 Study
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
